|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Oral contraceptive use and breast cancer in Indonesia. |
| Bustan MN; Coker AL; Addy CL; Macera CA; Greene F; Sampoerno D |
| CONTRACEPTION. 1993 Mar;47(3):241-9. |
| A hospital-based case-control study was conducted in Ujungpandang, Indonesia, to determine the association of |
| breast cancer and current and former oral contraceptive (OC) use. This study included 119 newly diagnosed, |
| histologically-confirmed, breast cancer cases who were admitted to the 4 largest referral hospitals in Ujungpandang |
| from 1990-91. Controls were 258 women admitted to these same 4 hospitals with diagnoses unrelated to breast |
| cancer or OC use. The odds ratio for ever using OCs and breast cancer was 1.8 (95% confidence interval 1.2-3.0) |
| after adjustment for age, age at 1st pregnancy, and family history of breast cancer. Increasing duration of OC use did |
| not increase risk of breast cancer. No latency trend of increasing years since 1st OC use among cases was |
| observed; however, a younger age at 1st OC use was associated with increasing breast cancer risk. A significant |
| recency effect was observed; women last using OCs within 5 years of study enrollment were at greatest risk of breast |
| cancer (OR = 4.9, 95% CI: 2.1-11.4). This 1st study of breast cancer and OC use in Indonesia does not provide |
| consistent data to indicate an increased risk of breast cancer associated with OC use. Although breast cancer |
| cases were 80% more likely to have ever used OCs, neither duration nor latency of OC use were associated with |
| cancer risk. The significant recency effect suggests that a detection bias might explain the observed relationship |
| between ever OC use and breast cancer. These results support the need for further studies which include |
| population-based controls. (PubHealth.info Document ID: CONT2T 4561-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptive use and breast cancer in Indonesia.", |
| is(are) Bustan MN; Coker AL; Addy CL; Macera CA; Greene F; Sampoerno D. The source of this article is |
| "CONTRACEPTION. 1993 Mar;47(3):241-9.". This article was published in 1993 in English language(s). |
| (PubHealth.info® Document ID: CONT2T 4561-06. All rights reserved with PubHealth.info) PIN: 9561 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |